To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The new capital and four major ...

Imagine you’re getting out of the shower one morning and you notice a mole on your thigh that you’ve never seen before. It’s reddish brown, bumpy and surprisingly large. Is it a benign mole, or is it ...

Imagine you’re getting out of the shower one morning and you notice a mole on your thigh that you’ve never seen before. It’s reddish brown, bumpy and surprisingly large. Is it a benign mole, or is it ...

DermaSensor today announced four new partnerships to accelerate growth of its skin-cancer-detecting device. Earlier this year, the Miami-based company received FDA clearance for DermaSensor, its ...

Too much ultraviolet (UV) exposure from the sun or tanning beds is the leading cause of most skin cancers. Anyone can develop skin cancer, but fair skin, a family history, older age, and a weakened ...

This paper presents a novel approach to skin, blood, and breast cancer detection using a penta-band Terahertz (THz) metamaterial absorber and deep learning. The proposed absorber, designed on a ...

Liquid biopsy is a promising, noninvasive approach for cancer detection, but current methods often trade off accuracy, operability, and cost. To address these limitations, we introduce an artificial ...

Cell-free DNA (cfDNA) in body fluids enables noninvasive cancer detection. Multifeature artificial intelligence (AI) can improve sensitivity by integrating diverse biomarkers when cancer signals are ...

Skin cancer is a pressing health issue that affects millions of individuals worldwide. Understanding how to check for skin cancer can be a vital skill in catching it early, which significantly ...

An AI technology already conducting one in nine urgent skin cancer assessments across the NHS is now certified for use on a standard smartphone. The development, unveiled at HLTH Europe, brings ...

[Image courtesy of DermaSensor] DermaSensor announced today that it received Class IIb CE mark approval for its skin cancer detection device. Miami-based Dermasensor develops a handheld device that ...

DermaSensor, the Miami-based health technology company that developed an AI-powered skin cancer detection device, is expanding into Europe after securing a key regulatory certification that opens the ...